NorthWest Biotherapeutics Inc (NWBO)

[beartrap12]

Hi Gary, I agree with everything you’ve said and I think part of the reason management delayed the publication of the JAMA article for 3 months is because they were waiting on manufacturing approval at Sawston and Flaskworks approval. I bet we see these approvals soon!

I'm not suggesting that a potential partner wouldn't take preferreds, but only if they know the company has sufficient shares authorized to convert them.

I think that’s what the increase in the share price is for…so a partner can convert shares if they want to. Yes, some may be used to keep the lights on during the run-up to more trials and more manufacturing. Or the partners may pay for some/all of the necessary up-scaling.
We’ll know soon.